title: [The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].
authors.forename: G A
authors.initials: GA
authors.lastname: El'shina
authors.forename: Iu M
authors.initials: IuM
authors.lastname: Masalin
authors.forename: V I
authors.initials: VI
authors.lastname: Shervali
authors.forename: M A
authors.initials: MA
authors.lastname: Gorbunov
authors.forename: N I
authors.initials: NI
authors.lastname: Lonskaia
authors.forename: L V
authors.initials: LV
authors.lastname: Agafonova
authors.forename: R M
authors.initials: RM
authors.lastname: Khaitov
authors.forename: A V
authors.initials: AV
authors.lastname: Nekrasov
authors.forename: A S
authors.initials: AS
authors.lastname: Ivanova
authors.forename: M N
authors.initials: MN
authors.lastname: Matrosovich
authors.forename: N G
authors.initials: NG
authors.lastname: Puchkova
mesh_terms: D000293:Adolescent; D000328:Adult; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control*; D017778:Vaccines, Combined / Q000009:adverse effects / Q000276:immunology; D015164:Vaccines, Inactivated / Q000009:adverse effects / Q000276:immunology
chemical_list: D007252:Influenza Vaccines; D017778:Vaccines, Combined; D015164:Vaccines, Inactivated